In this study, we analysed the differences in the immune environment between primary and lung metastatic lesions of STS using clinical samples and found that the infiltration of CD8+ T cells into the tumour core was significantly reduced in lung metastases of LMS. The gene discussed is CD8A; the disease is telomere syndrome.